Jennifer Lue

7PUBLICATIONS
59CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 10, 2026
Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma.

|Apr 29, 2026
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.

|Jul 02, 2025
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.

Sigrun Einarsdottir, Stephanie Lobaugh, Danny Luan

|Dec 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.

Pallawi Torka, Tatyana Feldman, Kerry J Savage

|Oct 14, 2024
Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes.

Jennifer K Lue, Efrat Luttwak, Alfredo Rivas-Delgado

|Jun 12, 2023
Retrospective characterization of nodal marginal zone lymphoma.

Robert Stuver, Esther Drill, David Qualls

Pageof 2

Frequent Collaborators

6 joint publications

Gilles Salles

5 joint publications

Ahmet Dogan

5 joint publications

Santosha Vardhana

5 joint publications

Anita Kumar